Long term follow up data of a phase II study of concurrent radiotherapy (RT) and gemcitabine (Gem) for patients with stage III or IV squamous cell carcinoma of the head and neck (SCCHN)

Pol Specenier,D. Van den Weyngaert,C. Van Laer,J. Van den Brande,Marjan Huizing,Sevilay Altintas,J.B. Vermorken

Long term follow up data of a phase II study of concurrent radiotherapy (RT) and gemcitabine (Gem) for patients with stage III or IV squamous cell carcinoma of the head and neck (SCCHN)

2006

Pol Specenier
D. Van den Weyngaert
C. Van Laer
J. Van den Brande
Marjan Huizing
Sevilay Altintas
J.B. Vermorken

5574 Background: RT with concurrent chemotherapy is superior to RT alone as treatment for locally advanced SCCHN. Gem is a potent radiosensitizer in vitro and in vivo and in addition has a good act...

Keywords:

Carcinoma
Radiation therapy
Cancer research
Gemcitabine
Medicine
Internal medicine
Oncology
head and neck
basal cell
Phases of clinical research
long term follow up
In vivo
Radiosensitizer

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations